ATOSSA THERAPEUTICS, INC. ATOS Cash Flow

Atossa therapeutics, inc. (ATOS)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
-2,947	-2,618	-3,285	-7,262	-4,073	-2,078	-3,309	-4,142	-1,874	-1,993	-2,184	-2,241	-1,703	-2,523	204	-1,722	-2,327	-4,961	-4,318	-3,145	-3,335	-	-	-	-	-	-	-	-	-	-	-	-1,062
Adjustments to reconcile net loss to net cash used in operating activities
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,813	-3,245	-3,187	-2,411	-2,757	-3,501	-2,583	-1,941	-	-	-	-
Net loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,371	-545	-23	-61	-	-	-	-	-	-	-	-	-	-	-	-
Bad debt expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16	36	27	-	-	-	-	-	-	-	-
Compensation cost for stock options granted
687	755	751	5,318	275	327	332	179	215	226	224	181	154	226	257	200	192	206	279	205	148	-	-	-	-	-	-	-	-	-	-	-	-
Disposal of assets
-	-	-	-	-	-	-	-	-	-35	35	0	-17	0	0	0	-163	-	81	-6	0	-	-	-	-	-	-	-	-	-	-	-	-
Common shares issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	155	0	0	0	0
Change in stock-based compensation liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	147	167	230	256	175	737	274	25	25	25	44
Loss on reduction on obsolete inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	6	0	23
Loan initiation fee accrued for notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Depreciation and amortization
12	12	12	13	13	15	10	9	7	26	28	33	40	76	74	76	75	104	112	-8	64	99	128	127	125	122	123	127	98	104	8	8	8
Change in fair value of stock-based compensation liability
-	-	-	-	1,741	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contingent loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Bad debt expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27	-2	-6	-19	-34	7	261	117	-33	-2	221	-44
Inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-87	35	-39	82	-36	43	1	0	-	-	-	-	0	6	47	-23
Prepaid expenses
474	432	-383	-22	325	219	-150	-55	244	93	-70	-66	123	50	-88	-18	34	72	-110	4	33	-72	-58	-115	245	129	-107	-54	90	82	-141	135	14
Research and development tax rebate receivable
-5	170	162	168	-280	37	-145	230	37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
108	24	1	-27	-2	-188	170	-5	-51	-	-	0	-25	-13	-20	0	-110	106	0	-123	128	-	-	-	-	-	-	-	-	-	-	-	-
Security deposits
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43	4	-47	0	1	2	0	-32
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17	0	24	-	-	-	-	-	-	-	-
Accounts payable
63	-208	183	-145	110	-197	359	22	-166	-45	-115	108	132	56	-85	-146	-385	-106	340	-385	453	73	-350	499	42	-21	-20	16	-33	-3	0	-25	31
Decrease (Increase) in accrued payroll
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	94	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13	2	3	4	-6	-12	-13	-13	-12	-11	72	0	-	-	-	-
Product recall liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3	-8	-84	-115	-	-	-	-	-	-	-	-
Accrued expenses
-25	-147	171	-21	-102	125	-235	114	82	39	6	9	17	4	-63	-93	-294	1,210	-537	-347	-115	47	167	-96	-75	-399	-351	-232	279	-292	811	644	35
Payroll liabilities
-433	129	180	-302	-43	228	-246	596	-428	157	145	151	-439	134	142	-231	-434	136	294	-688	456	173	173	182	-150	-	-	-	-	-	-	-	-
Product recall liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	402	0	0	-	-	-	-
Other current liabilities
-9	-5	-1	9	-30	-26	42	0	7	2	-5	-3	16	-12	-3	18	-60	49	-4	-24	0	-79	7	-5	-13	-28	-11	86	-55	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,659	-2,994	-1,047	-3,563	-4,203	-2,505	-625	-2,977	-2,254	-2,603	-2,647	-2,737	-2,109	-1,334	-	-	-	-
Net cash used in discontinued operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,906	82	682	-493	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-3,229	-2,708	-1,768	-2,502	-2,148	-2,443	-2,298	-1,832	-2,386	-1,682	-1,701	-1,348	-1,860	-	-	-	-	-3,953	-3,480	-3,520	-2,998	-	-	-	-	-	-	-	-	-	-150	-811	-1,005
CASH FLOWS FROM INVESTING ACTIVITY
Purchase of furniture and equipment
-	-	-	-	-	56	2	0	51	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of furniture, fixtures and equipment
-	-	-	-	-	-	-	-	-	-	0	0	0	4	0	-0	5	79	109	-86	28	-261	81	17	2	-101	264	81	0	104	0	0	0
Purchases of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-21	14	70	100	190	46	0	8	30	0	0	0
Net cash used in continuing investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-63	-109	70	-28	282	-96	-88	-102	-89	-310	-81	-8	-	-	-	-
Net cash used in discontinued investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-113	80	-86	-37	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-56	-2	-0	-51	-	0	0	0	-4	-0	0	-5	-177	-29	-15	-66	-	-	-	-	-	-	-	-	-	0	0	0
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from exercise of warrants
0	0	0	0	11,336	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,561	-32	2,166	-41	-4	5,210	4,292	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock and warrants, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12,955	1,385	8,302	3,244	1,003	3,454	400	0	0
Repayments from bank line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-250	0	0	-750
Repayments of loans from related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-80	81	0	-6
Cash released from commercial line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	250	0	0	750
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-32	2,166	7	-53	5,210	4,292	-98	150	50	12,955	1,385	8,302	3,244	1,003	-	-	-	-
Net cash provided by financing activities
-	0	0	0	11,336	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	481	0	-6
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
-3,229	-2,708	-1,768	-2,509	9,187	-2,500	-2,301	10,457	-2,437	4,483	-956	2,523	-1,860	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
SUPPLEMENTAL DISCLOSURES
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
-	-	-	-	-	-	-	-	-	-	-	-	-	-1,360	3,197	-1,691	-833	-4,123	-3,563	1,674	1,227	-2,873	-2,924	-2,292	10,248	-1,351	5,254	1,054	-339	1,306	330	-811	-1,011
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2	0	1	1	13	0	1	0	0	0	-2	2	0	7	4	1
Income taxes paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
NONCASH INVESTING AND FINANCING ACTIVITIES
Reclassification of stock-based liability awards to equity upon cancellation
-	0	0	0	3,151	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of commitment shares
-	-	-	-	-	13	19	19	19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of commitment shares issued for shares distributed for capital contribution
-	-	-	-	-	-	-	-	-	-	19	19	19	16	19	6	0	-37	0	40	351	-	-	-	-	-	-	-	-	-	-	-	-
Common stock and warrants issued for asset purchase
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	4,674	0	0
Noncash reclassification of prepaid license fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	15	-	-	-	0	-	-	-	-
Options issued for previously accrued director compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	45	0	0
Commitment shares distributed for capital contribution
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,387	0	0	0	0
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-75	75	-	-	-	79	0	0	0	0